ahankard.bsky.social
@ahankard.bsky.social
Reposted
Data-Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis
https://pubmed.ncbi.nlm.nih.gov/40317798
May 5, 2025 at 10:06 AM
Reposted
Patients with cancer and VTE are at risk for VTE recurrence, and there are limited data on appropriate and effective anticoagulation regimens beyond 6 months. Findings from the API-CAT trial are summarized in a short video.
Reduced-Dose Apixaban for Cancer-Associated VTE (API-CAT Trial) | NEJM
Patients with cancer and VTE are at risk for VTE recurrence, and there are limited data on appropriate and effective anticoagulation regimens beyond 6 months...
youtu.be
April 12, 2025 at 7:00 PM
Reposted
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis - PubMed
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a prototypic autoimmune disease, with a subset of AAV patients manifesting anti-myeloperoxidase (MPO) IgG. Patients with AAV ...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 6:46 AM
Reposted
Happy to share our latest publication! Here we document the spatial distribution of fibroblast subtypes in relation to vascular remodeling in GCA. Great work by Shuang Xu William Febry Jiemy and Maria Sandovici!
academic.oup.com/rheumatology...
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis
AbstractObjective. Giant cell arteritis (GCA) is a systemic vasculitis of large- and medium-sized arteries characterized by granulomatous inflammation and
academic.oup.com
March 18, 2025 at 4:22 PM
Reposted
Avacopan Versus Prednisone Taper in Patients With ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial

Sponsored by Amgen

buff.ly/MqOmXhk
March 4, 2025 at 5:01 PM